---
title: "Wolwo Pharma 2024 Q1-Q3 dividend distribution: 1 yuan for every 10 shares, with the record date on January 9"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/223794546.md"
description: "According to the announcement from WuXi AppTec, the company's equity distribution plan for the first three quarters of 2024 is: based on the current total share capital of the company, a cash dividend of RMB 1 (including tax) will be distributed for every 10 shares to all shareholders. The equity distribution record date is January 9, 2025, and the ex-dividend date is January 10, 2025"
datetime: "2025-01-02T11:56:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/223794546.md)
  - [en](https://longbridge.com/en/news/223794546.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/223794546.md)
generator: "portal-rs"
---

# Wolwo Pharma 2024 Q1-Q3 dividend distribution: 1 yuan for every 10 shares, with the record date on January 9

According to the announcement from WuXi AppTec (300357.SZ), the equity distribution plan for the first three quarters of 2024 is as follows: based on the company's existing total share capital, a cash dividend of RMB 1 per 10 shares (including tax) will be distributed to all shareholders. The equity distribution record date is January 9, 2025, and the ex-dividend date is January 10, 2025

### Related Stocks

- [300357.CN](https://longbridge.com/en/quote/300357.CN.md)

## Related News & Research

- [The Outlook for a Smaller Ghana Cocoa Crop Supports Prices](https://longbridge.com/en/news/296516744.md)
- [Signs of Abundant Cocoa Supplies Undercut Prices](https://longbridge.com/en/news/296810940.md)
- [Copper Above $14,200 a Ton, With Global Inventory Shifts in Focus](https://longbridge.com/en/news/296771972.md)
- [LibertyStream reports three months of battery-grade lithium carbonate output at 99.7%+ purity](https://longbridge.com/en/news/296788400.md)
- [Weekly Recap: Two interim dividends paid and selective iron‑ore bidding](https://longbridge.com/en/news/296720277.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**